Author Correction: Targeting the SHOC2-RAS interaction in RAS-mutant cancers.
Hauseman ZJ, Stauffer F, Beyer KS, Mollé S, Cavicchioli E, Marchand JR, Fodor M, Viscomi J, Dhembi A, Katz S, Faggion B, Lanter M, Kerr G, Schildknecht D, Handl C, Maddalo D, Pissot Soldermann C, Brady J, Shrestha O, Nguyen Z, Leder L, Cremosnik G, Lopez Romero S, Hassiepen U, Stams T, Linder M, Galli GG, Guthy DA, King DA, Maira SM, Thoma CR, Ehmke V, Tordella L.
Hauseman ZJ, et al. Among authors: linder m.
Nature. 2025 Jul 1. doi: 10.1038/s41586-025-09309-z. Online ahead of print.
Nature. 2025.
PMID: 40595365
No abstract available.